Huashan Hospital
Shanghai, Shanghai Municipality, 200040, China
Location status: Recruiting
NCT Number: NCT07672522
This prospective observational cohort study aims to investigate the relationship between immunosenescence and infectious diseases in older adults. Individuals aged 60 years and older, including elderly patients with infections and healthy controls, will be enrolled and followed longitudinally.
Clinical information, laboratory test results, and health assessment data will be collected. Biological specimens, including peripheral blood, urine, stool, sputum, and nasopharyngeal swabs, will be obtained during enrollment and follow-up. Participants will undergo regular assessments of health status, infection events, and aging-related clinical characteristics.
The study will evaluate age-related changes in immune function, immune cell composition, immune receptor repertoires, epigenetic characteristics, metabolic profiles, and respiratory and gut microbiota. By integrating clinical and multi-omics data, the study aims to identify biomarkers associated with immunosenescence, susceptibility to infection, disease severity, and clinical outcomes in older adults.
The results are expected to improve understanding of the mechanisms linking aging, immune dysfunction, and infectious diseases, and to support the development of predictive models and preventive strategies for infection management and healthy aging in elderly populations.
Interested in participating?
Request Info60 year and older
All sexes
Observational
Shanghai, Shanghai Municipality, 200040, China
Location status: Recruiting
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
for the Healthy Control Group
Inclusion criteria
for the Infection Group 1.Age: 60 years or older; no gender restrictions. 2. Clinically diagnosed with an infectious disease by the treating physician. 3. The participant provides informed consent and signs the relevant documents.
-------------- Exclusion Criteria for the Healthy Control Group
Exclusion criteria
for the Infection Group
Time frame: Baseline to 5 years
Proportion of peripheral blood immune cell subsets in the infection group versus the healthy control group.
Time frame: Baseline to 5 years
Chromatin accessibility of peripheral blood mononuclear cells.
Time frame: Baseline to 5 years
Abundance of metabolites in plasma and urine.
Time frame: Baseline to 5 years
Diversity of respiratory tract and gut microbiota, measured by microbiome sequencing and reported as the Shannon diversity index.
Contact information is provided by the study sponsor or research team.
Huashan Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07341087
Acne, Acne Vulgaris
London, United Kingdom
View Trial DetailsNCT07239830
Immunosenescence, Uninfected Older
Villeurbanne, France
View Trial DetailsNCT07000708
Behavior, Fasting
Berlin, Germany
View Trial DetailsNCT05322343
Aging, Alzheimer Disease
Bordeaux, France
View Trial Details